A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies

NCT02097745 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: methotrexate
DRUG: rituximab [MabThera/Rituxan]

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]